Immunomodulation of Delayed Hypersensitivity to Methylated Bovine Serum Albumin (MBSA) in Mice Using Subliminal and Normal Sensitization Procedures

References

• Renoux G. Modulation of immunity by levamisole. Pharmac. Thera. A. 1978; 2: 397
   Web of Science ®Google Scholar
• Griswold D. E., Walz D. T. Condition-dependent imnuno-regulatory control of contact sensitivity by levamisole. Inflammation 1977; 2: 277
   PubMedGoogle Scholar
• Cunningham F. M., Ford-Hutchinson A. W., Oliver A. M., Smith M. J.H., Walker J. R. The effects of d-penicillamine and levamisole on leukocyte chemotaxis in the rat. Br. J. Pharmacol. 1978; 63: 119
   Google Scholar
• Cottney J., Bruin J., Lewis A. J. Modulation of the immune system in the mouse. 1. Drug administration prior to antigen sensitization. Agents and Actions 1980; 10: 378
   Google Scholar
• Cottney J., Bruin J., Lewis A. J. Modulation of the immune system in the mouse, 2. Drug administration following antigen sensitization. Agents and Actions 1980; 10: 48
   PubMedGoogle Scholar
• Arrigoni-Martelli E., Bramm E., Huskisson E. C., Willoughby D. A., Dieppe P. A. Pertussis vaccine edema: an experimental model for the action of penicillamine-like drugs. Agents and Actions 1976; 6: 613
   Google Scholar
• Lewis A. J., Parker J., DiLuigi J., Datko L., Carlson R. P. Immunomodulation of delayed hypersensitivity to methylated bovine serum albumin (MBSA) in mice. Fed. Proc. 1981; 40: 990
   Google Scholar
• Hambleton P., Miller P., Robson E., Smith S. Differential modulation of delayed hypersensitivity. Br. J. Pharmacol. 1980; 70: 1868
   Google Scholar
• Lewis A. J., DiLuigi J., Parker J., Datko L., Carlson R. P. Wy-18,251 (3-(p-chlorophenyl) thiazole[3,2-a]benzimidazole-2-acetic acid); a novel immunomodulator drug with antiinflammatory properties. Fed. Proc. 1981; 40: 1005
   Google Scholar
• Fenichel R. L., Alburn H. E., Schreck P. A., Bloom R., Gregory F. J. Immunomodulating and antimetastatic activity of 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid (Wy-18,251, NSC 310633). J. Immunopharmacol. 1980; 2: 491
   PubMed Web of Science ®Google Scholar
• Parrillo J. E., Fauci A. S. Mechanisms of glucocorticoid action on immune processes. Ann. Rev. Pharmacol. Toxicol. 1979; 19: 179
   PubMed Web of Science ®Google Scholar
• Cunningham F. M., Ford-Hutchinson A. W., Smith M. J.H., Walker J. R. Effects of d-penicillamine and levamisole on delayed hypersensitivity reactions in the rat and mouse. Br. J. Pharmacol. 1978; 62: 423P
   Google Scholar
• Dieppe P. A., Willoughby D. A., Huskisson E. C., Arrigoni-Martelli E. Pertussis vaccine pleurisy: a model of delayed hypersensitivity. Agents and Actions 1976; 6: 618
   Google Scholar
• Arrigoni-Martelli Brauun E.E., Binderup L. Immunostimulant activity of d-penicillamine. Drugs Exptl. Clin. Res. 1977; 2: 189
   Google Scholar
• Umezawa H., Ishizuka M., Aoyagi T., Takeuchi T. Enhancement of delayed-type hypersensitivity by bestatin, an inhibitor of aminopeptidase B and leucine aminopeptidase. J. Antibiotics 1976; 29: 857
   PubMed Web of Science ®Google Scholar
• Wooles W. R. Reticuloendothelial function and the immune response. Science 1963; 142: 1078
   PubMedGoogle Scholar
• Stewart-Tull D. E.S. The immunological activities of bacterial peptidoglycans. Ann. Rev. Microbiol. 1980; 34: 311
   PubMed Web of Science ®Google Scholar
• Walz D. T., Griswold D. E. Immunopharmacology of gold sodium thiomalate and auranofin (SK&F D-39162). Inflammation 1978; 3: 117
   PubMedGoogle Scholar
• Lewis A. J., Walz D. T. The immunopharmacology of gold salts. Progr. Med. Chem., in press
   Google Scholar
• Borel J. F., Feurer C., Gubler B. V., Stahelin H. Biological effects of cyclosporin A: a new anti-lymphocytic agent. Agents and Actions 1976; 6: 468
   PubMedGoogle Scholar
• Borel J. F., Feurer C., Magnee C., Stahelin H. Effects of the new antilymphocytic peptide cyclosporin A in animals. Immunology 1977; 32: 1017
   PubMed Web of Science ®Google Scholar
• Cashin C. H., Gill J., Jones S. A., Kennedy A. J. An assessment of the delayed hypersensitivity reaction to methylated bovine serum albumin in the mouse and its use in the evaluation of drug effects on cell mediated immune reactions. Agents and Actions 1979; 9: 553
   Google Scholar
• Shand F. L. The immunopharmacology of cyclophosphamide. Int. J. Immunopharmac. 1979; 1: 165
   PubMed Web of Science ®Google Scholar
• Megel H., Raychaudhuri A., Goldstein S., Kinsolving C. R., Shemano I., Michael J. E. Tilorone: its selective effect on humoral and cell mediated immunity. Proc. Soc. Exp. Biol. Med. 1974; 745: 513
   Google Scholar
• Daniels J. C., Warren K. S., David J. R. Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compound niridazole. J. Immunol. 1975; 115: 1414
   Google Scholar
• Crowle A. J. Delayed hypersensitivity in the mouse. Adv. Immunol. 1975; 20: 197
   PubMedGoogle Scholar
• Askenase P. W. The role of basophils, mast cells and vasoamines in hypersensitivity reactions with a delayed time course. Progr. Allergy 1977; 23: 199
   PubMedGoogle Scholar
• Lewis A. J., Carlson R. P., Dervinis A., Capetola R. J., Rosenthale M. E. The antiallergic activity of Wy-41, 195. Fed. Proc. 1980; 39: 1017
   Google Scholar
• van Dijk H., Rademaker P. M., Kerkhofs J. P., Willers J. M.N. Histamine 2-receptor-mediated immunomodulation in the mouse. II. Inmunomodulation by the H2 antagonist metiamide. Int. J. Immunopharmac. 1980; 2: 345
   Google Scholar
• Askenase P. W. Histamine 2-antagonist inhibition of delayed hypersensitivity (DH). Clin. Res. 1977; 25: 481
   Google Scholar
• Avella J., Madsen J. E., Binder H. J., Askenase P. W. Effect of histamine H2-receptor antagonists on delayed hypersensitivity. Lancet 1978; i: 624
   Google Scholar
• Gershon R. K., Askenase P. W., Gershon M. D. Requirement for vasoactive amines for production of delayed-type hypersensitivity skin reactions. J. exp. Med. 1975; 142: 732
   PubMedGoogle Scholar